Mechanism

Glypican-3 (GPC3)

Assets acting on this target.

Class
GPC3-directed antibody-drug conjugate (ZD06519, camptothecin-derived topoisomerase-1 inhibitor payload, DAR4, cleavable linker)
Pathway
Antibody-mediated internalization delivering a bystander-active topoisomerase I inhibitor
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

0 of 0 assets

No assets match these filters.

← all assets